The NHS will appoint community pharmacy managers for each integrated health system
NHS England is funding the creation of 42 community pharmacy clinical leadership positions across the country “to support the scaling up and integration of new clinical services” in the sector, he said.
In a letter sent to NHS Regional Directors and Regional Chief Pharmacists on February 2, 2022, and seen by The Pharmaceutical JournalNHS England says each integrated care system (ICS) will be able to recruit for these positions from April 2022.
According to current annual salary scales.
Salaries will be funded through the Pharmacy Integration Program for two years, after which CNSs will be required to “make their own ongoing arrangements to continue the integration and expansion of community pharmacy clinical services,” the letter states.
As well as supporting the integration of new clinical services, the letter says clinical leaders will work closely with NHS trusts in their ICS “to integrate referral pathways and support an integrated approach to service delivery. community pharmacy clinics”.
The letter from NHS England added that “new permanent AfC 8d Regional Pharmacy Integration Manager positions have been created, reporting to the Regional Chief Pharmacists and recruitment for these positions is ongoing”.
These positions – paid up to £90,387 a year – will also be supported by two-year funding through the Pharmacy Onboarding Scheme, after which “regional budgets will take over”.
Plans for CNSs to recruit Community Pharmacy Integration Leads were initially shared by NHS England in October 2021, when it was announced that those in the positions would be responsible for leading implementation local community pharmacy clinical services.
In a tweet posted on February 2, 2022, David Webb, Chief Pharmaceutical Officer for England, said clinical lead roles would “further support the delivery of clinical community pharmacy services for patients”.
However, the Company Chemists’ Association (CCA) has stated February 2, 2022 that, while welcoming the additional roles, “efforts to accelerate the introduction of new clinical services must be supported by sustainable funding and material actions to increase the workforce in the sector”.
“We are concerned that without the funding and the people in place, the desired volume of necessary services cannot be provided, no matter how well coordinated,” the CCA said.
Thorrun Govind, Chairman of the Royal Pharmaceutical Society (RPS) English Pharmacy Council, said it was “great to see the NHS investing in local and regional pharmacy leadership to support the integration of pharmacy and help to make new services a success, while ensuring community pharmacy integration into broader ICS plans for the future”.
“These new roles now need to get the time, support and resources they need to make an impact and deliver better outcomes for their local people, and we encourage pharmacists to apply for these positions,” she said. declared.
“Our recent recommendations developed with our ICS Pharmacy Leads Forum emphasize the key role of pharmacists in promoting collaboration within the health service, improving patient care and supporting medication optimization.
What are Integrated Care Systems?
Integrated Care Systems (ICS) were developed from Sustainability and Transformation Partnerships (STPs), which were formed in 2016 as local partnerships between NHS organizations and tasked with developing plans for the future of local care.
In the “NHS Long Term Plan”, published in January 2019, it was announced that the ICS would be set up to cover every region of the country by April 2021 in order to “bring together local organizations in a pragmatic and practical way”. .
In February 2021, a NHS White Paper established plans to give legal status to ICS, taking on the functions of Clinical Commissioning Groups (CCGs) and incorporating a “duty of collaboration” between the NHS and local authorities.
The following Health and Care Billwhich was tabled in Parliament on July 6, 2021 and is currently going through the House of Lords, developed these plans.
It states that each ICS will be led by an Integrated Care Board (ICB), which will take over the commissioning functions currently held by the CCGs – the latter being abolished.
This change was originally scheduled for April 2022 but has now been delayed to July 2022 to “allow more time for the remaining parliamentary steps and allow organizations to manage their most immediate pandemic response priorities”, NHS Digital said in a statement. update published on January 5, 2022.
In October 2021, the Pharmaceutical Services Negotiating Committee and other primary care bodies wrote to the Parliamentary Committee reviewing the Bill to request that pharmacists and other primary health care professionals be represented on ICBs.
Read more: Collaboration not competition: the NHS blueprint to keep patients out of hospital